The Ademi Firm is investigating Blueprint (Nasdaq: BPMC) and its transaction with Sanofi . Click here to learn how to join our investigation and obtain...
The Ademi Firm is investigating Blueprint (Nasdaq: BPMC) and its transaction with Sanofi . Click here to learn how to join our investigation and obtain...
NEW YORK , July 18, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions...
June S&P 500 E-Mini futures (ESM25) are down -0.57%, and June Nasdaq 100 E-Mini futures (NQM25) are down -0.69% this morning, starting the new month on a downbeat note as escalating global trade tensions...
Blueprint Medicines: Q1 Earnings Snapshot
Blueprint Medicines: Q4 Earnings Snapshot
Shares of Blueprint Medicines BPMC rallied 18.2% on Monday driven by investor enthusiasm following the company’s announcement of its 2025 corporate outlook and growth strategy, highlighting plans to...
Ariel Hurley, the PRINCIPAL ACCOUNTING OFFICER of $BPMC ($BPMC), sold 1,200 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...
Christina Rossi, the CHIEF OPERATING OFFICER of $BPMC ($BPMC), sold 2,274 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.1%...
Blueprint Medicines: Q3 Earnings Snapshot